--- title: "Quantum BioPharma settles CAD 123,487 debt with 30,948 shares at CAD 3.99 each" type: "News" locale: "en" url: "https://longbridge.com/en/news/294300672.md" description: "Quantum BioPharma settled a debt of CAD 123,487.43 by issuing 30,948 Class B subordinate voting shares at a deemed price of CAD 3.99 per share, based on the prior CSE closing price. The settlement covered amounts owed to both arm’s-length creditors and insiders." datetime: "2026-07-30T04:29:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294300672.md) - [en](https://longbridge.com/en/news/294300672.md) - [zh-HK](https://longbridge.com/zh-HK/news/294300672.md) generator: "portal-rs" --- # Quantum BioPharma settles CAD 123,487 debt with 30,948 shares at CAD 3.99 each - Quantum BioPharma closed a debt settlement of CAD 123,487.43 via issuance of 30,948 Class B subordinate voting shares. \* Shares were issued at a deemed price of CAD 3.99, based on the prior CSE closing price. \* Settlement covered amounts owed to arm’s-length creditors and insiders. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [QNTM.US](https://longbridge.com/en/quote/QNTM.US.md) ## Related News & Research - [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves](https://longbridge.com/en/news/296514765.md) - [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2](https://longbridge.com/en/news/296129489.md) - [BioSyent GAAP EPS of C$0.25, revenue of C$19.87M](https://longbridge.com/en/news/296538491.md) - [Evolve Future Leadership Fund - ETF Hedged declares CAD 0.21 dividend](https://longbridge.com/en/news/296299467.md) - [Insider Selling: Alvopetro Energy (CVE:ALV) Director Sells 10,200 Shares](https://longbridge.com/en/news/296081468.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**